| |
| |
|
| Insider
Information: |
Chin Mark |
| Relationship: |
Former Director |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
85,137 |
|
|
Indirect Shares
|
4,916,431 |
|
|
| Direct
Value |
$30,571 |
|
|
|
Indirect Value
|
$2,299,174 |
|
|
| Total
Shares |
5,001,568 |
|
|
| Total
Value |
$2,329,745 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iterum Therapeutics Plc |
ITRM |
Director |
2023-06-15 |
18,306 |
2020-04-07 |
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2019-12-17 |
2,572,359 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
Director |
2020-03-16 |
0 |
2021-07-16 |
2,344,072 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
Former Director |
2022-03-31 |
66,831 |
2022-04-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,224) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
424 |
13,224 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,072 |
12,801 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
11,729 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,035 |
6,729 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • – |
2023-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,656 |
36,941 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,853 |
18,306 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,798 |
36,798 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Former Director |
– – – |
2022-04-21 |
4 |
S |
$3.05 |
$5,324,571 |
I/I |
(1,745,761) |
0 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
|
• • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
66,831 |
66,831 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
|
• • – |
2021-10-13 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
1,745,761 |
0.01 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
|
• • – |
2021-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,433,261 |
1,433,261 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • – |
2021-07-16 |
4 |
B |
$6.00 |
$7,999,998 |
I/I |
1,333,333 |
2,344,072 |
2.1 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2020-07-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,857) |
0 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,703 |
11,857 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2020-04-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,089,903) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2020-03-16 |
4 |
B |
$16.00 |
$3,000,000 |
I/I |
187,500 |
1,554,558 |
2.25 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,367,058 |
1,367,058 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-17 |
4 |
S |
$16.83 |
$209,969 |
I/I |
(12,476) |
2,572,359 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-16 |
4 |
S |
$17.02 |
$222,680 |
I/I |
(13,080) |
2,584,835 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-13 |
4 |
S |
$17.21 |
$189,341 |
I/I |
(11,002) |
2,597,915 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-10 |
4 |
S |
$16.91 |
$2,227,019 |
I/I |
(131,696) |
2,608,917 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-09 |
4 |
S |
$18.12 |
$1,884,445 |
I/I |
(103,754) |
2,740,613 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-12-06 |
4 |
S |
$19.15 |
$914,222 |
I/I |
(47,752) |
2,844,367 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2019-05-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,154 |
6,154 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
